Evidence map›Paper›PMID 36869213›Full record

ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2023

Corynebacterium guaraldiae sp. nov.: a new species of Corynebacterium from human infections.

Lincoln de Oliveira Sant'Anna, Louisy Sanches Dos Santos, Max Roberto Batista Araújo, Danilo Jobim Passos Gil da Rocha, Juliana Nunes Ramos, Paulo Victor Pereira Baio, Pedro Fernandez Del Peloso, Cassiana da Costa Ferreira Leite, Renata Stavrakakis Peixoto, Marisa Almuzara and 8 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 4 countries.

Lincoln de Oliveira Sant'AnnaLaboratory of Diphtheria and Corynebacteria of Clinical Relevance, Department of Microbiology, Immunology and Parasitology, State University of Rio de Janeiro, Rio de Janeiro, Brazil. lincolnsantanna.microuerj@gmail.com.ORCID http://orcid.org/0000-0002-6933-8961
Louisy Sanches Dos SantosLaboratory of Diphtheria and Corynebacteria of Clinical Relevance, Department of Microbiology, Immunology and Parasitology, State University of Rio de Janeiro, Rio de Janeiro, Brazil.
Max Roberto Batista AraújoHermes Pardini Institute, Vespasiano, Brazil.
Danilo Jobim Passos Gil da RochaDepartment of Biotechnology, Institute of Health Sciences, Federal University of Bahia, Salvador, Brazil.
Juliana Nunes RamosLaboratory of Diphtheria and Corynebacteria of Clinical Relevance, Department of Microbiology, Immunology and Parasitology, State University of Rio de Janeiro, Rio de Janeiro, Brazil.
Paulo Victor Pereira BaioArmy Chemical and Pharmaceutical Laboratory, Ministry of Defense, Brasília, Brazil.
Pedro Fernandez Del PelosoRichet Laboratory, Rio de Janeiro, Brazil.
Cassiana da Costa Ferreira LeiteRichet Laboratory, Rio de Janeiro, Brazil.
Renata Stavrakakis PeixotoProfessur Fuer Mikrobiologie, Friedrich-Alexander-Universität Erlagen-Nürnberg, Erlangen, Germany.
Marisa AlmuzaraFaculty of Pharmacy and Biochemistry and Bacteriology, Department of Clinical Biochemistry, University of Buenos Aires, Autonomous City of Buenos Aires, Buenos Aires, Argentina.
Carlos VayFaculty of Pharmacy and Biochemistry and Bacteriology, Department of Clinical Biochemistry, University of Buenos Aires, Autonomous City of Buenos Aires, Buenos Aires, Argentina.
Claudia BarberisFaculty of Pharmacy and Biochemistry and Bacteriology, Department of Clinical Biochemistry, University of Buenos Aires, Autonomous City of Buenos Aires, Buenos Aires, Argentina.
Vartul SangalFaculty of Health and Life Sciences, Northumbria University, Newcastle Upon Tyne, UK.
Andreas BurkovskiProfessur Fuer Mikrobiologie, Friedrich-Alexander-Universität Erlagen-Nürnberg, Erlangen, Germany.
Eric Roberto Guimarães Rocha AguiarVirus Bioinformatics Laboratory, Center of Biotechnology and Genetics, Department of Biological Sciences, State University of Santa Cruz, Ilhéus, Brazil.
Ana Luíza Mattos-GuaraldiLaboratory of Diphtheria and Corynebacteria of Clinical Relevance, Department of Microbiology, Immunology and Parasitology, State University of Rio de Janeiro, Rio de Janeiro, Brazil.
Luis Gustavo Carvalho PachecoDepartment of Biotechnology, Institute of Health Sciences, Federal University of Bahia, Salvador, Brazil.
Verônica Viana VieiraInterdisciplinary Laboratory of Medical Research, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Universidade do Estado do Rio de Janeiro · BRUniversidad de Buenos Aires · ARFriedrich-Alexander-Universität Erlangen-Nürnberg · DEUniversidade Federal da Bahia · BRFundação Oswaldo Cruz · BRMinistry of Defence · BRNorthumbria University · GBUniversidade Estadual de Santa Cruz · BR

Funding

Lacrimal Gland Repair Using Progenitor CellsR01EY026202 · NEI · SCRIPPS RESEARCH INSTITUTE, THE · PI MAKARENKOVA, HELEN P. · 2016 to 2025
$5.2M
Conselho Nacional de Desenvolvimento Científico e Tecnológico 309948/2018-5Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 1732263Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 88882.315426/2019-01Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 88882.450376/2019-01Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro E-26/202.087/2020Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro E-26/202.088/2020Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro E-26/210.889/2019Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro E-26/211.629/2015Fundação Oswaldo Cruz 7481297331Secretaria de Ciencia y Tecnica, Universidad de Buenos Aires 20020170100109 BA
6 · The paper itself

Abstract

Non-diphtheria Corynebacterium species (NDC) belonging to the human skin and mucosa microbiota are frequently neglected as contaminants. However, reports of human infections by Corynebacterium spp. have increased considerably in recent years. In this study, a group of six NDC isolates of urine (n = 5) and sebaceous cyst (n = 1) from two South American countries were identified at genus level or misidentified based on API® Coryne and genetic/molecular analyses. The 16S rRNA (99.09-99.56%) and rpoB (96.18-97.14%) gene sequence similarities of the isolates were higher when compared with Corynebacterium aurimucosum DSM 44532

Indexed as

CorynebacteriumDNABacterial Typing TechniquesDNA, BacterialFatty AcidsHumansNucleic Acid HybridizationPhylogenyRNA, Ribosomal, 16SSequence Analysis, DNADNADNA, BacterialFatty AcidsRNA, Ribosomal, 16SClassificationCorynebacteriumCorynebacterium guaraldiae sp. nov.Epidermal cystUrinary tract infection

Identifiers

PMID36869213
PMCPMC10235285
OpenAlexW4323037941

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.